Name | 6-[(E)-(2-Amino-4-hydroxy-5-methylphenyl)diazenyl]-3,4-dihydro-2(1H)-quinolinone |
---|---|
Synonyms |
6-[(E)-(2-Amino-4-hydroxy-5-methylphenyl)diazenyl]-3,4-dihydro-2(1H)-quinolinone
2(1H)-Quinolinone, 6-[(E)-2-(2-amino-4-hydroxy-5-methylphenyl)diazenyl]-3,4-dihydro- |
Description | ZL0420 is a potent, highly selective BRD4 inhibitor with IC50 of 27 and 32 nM for BRD4-BD1 and BRD4-BD2, respectively; displays selectivity over BRD2, BRD3, and BRDT (BRD2-BD1 and BRD2-BD2, IC50=803 and 1736 nM); disrupts the BRD4 complex with Pol II and histones, inhibits poly(I:C)-induced expression of innate immune genes IL6 and CIG5 in human small airway epithelial cells (hSAECs) (IC50=0.54 and 0.51 uM); blocks Poly(I:C)-induced inflammation and neutrophilia in vivo. |
---|---|
References | References 1. Tian B, et al. Cell Rep. 2018 Apr 24;23(4):1138-1151. 2. Liu Z, et al. Eur J Med Chem 2018 May 10;151:450-461. View Related Products by Target Bromodomain |
Density | 1.4±0.1 g/cm3 |
---|---|
Boiling Point | 645.9±55.0 °C at 760 mmHg |
Molecular Formula | C16H16N4O2 |
Molecular Weight | 296.324 |
Flash Point | 344.4±31.5 °C |
Exact Mass | 296.127319 |
LogP | 2.19 |
Vapour Pressure | 0.0±2.0 mmHg at 25°C |
Index of Refraction | 1.704 |
Storage condition | -20℃ |